logo-loader
Health
TransEnterix Inc.

TransEnterix shares pop after FDA clears robotic surgery instruments

The FDA’s clearance of the 3 millimeter diameter instruments will allow the company’s Senhance robotic surgery system to be used for microlaparoscopic surgeries

FDA approved button on PC keyboard
The addition of 3 millimeter instruments will allow high-volume surgeries with even smaller incisions

The medical device company TransEnterix (NYSEAMERICAN:TRXC) is on the receiving end of good news from the US Food and Drug Administration which has awarded 510(k) clearance for its 3 millimeter as well as additional 5 millimeter Senhance system instruments.

The FDA’s clearance of the 3 millimeter diameter instruments will pave the way for the company’s Senhance robotic surgery system to be used for microlaparoscopic surgeries that enable surgeons to operate through tiny incisions that don’t leave patients with severe scarring.

Investors also welcomed the FDA’s move, sending Transenterix shares up 13% to $5.06 before Thursday’s opening bell.

READ:TransEnterix posts bigger 2Q loss although revenue tops expectation

Todd Pope, CEO of TransEnterix, said the FDA’s acceptance of its 3 millimeter instruments represents an “unparalleled shift” in robotic surgery.

“The addition of 3 millimeter instruments will allow many high volume surgeries to be performed with smaller incisions, which supports our mission of advancing minimally invasive surgical capabilities within digital laparoscopy,” Pope said in a statement.

Based in Morrisville, North Carolina, TransEnterix is a pioneer in the use of robotics to advance minimally-invasive surgery.

Contact Ellen Kelleher at [email protected]

Quick facts: TransEnterix Inc.

Price: $0.73

Market: NYSE
Market Cap: $165.47 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Highgold Mining begins trading on the Venture exchange under...

Highgold Mining (CVE: HIGH) President ad CEO Darin Green sat down with Steve Darling from Proactive Vancouver to discuss their brand new company that has just gone public. Green telling Proactive about their strong management team and their stable of properties with big upside.

34 minutes ago

2 min read